Florida House Business & Professions Subcommittee: Regulating Tobacco Products (October 23, 2019)
Summary
A meeting packet for the House Business & Professions Subcommittee dated October 23, 2019, made up of slide presentations. The Department of Business & Professional Regulation slides state that during FY 2018- 19 the Division collected over $254,000,000 in cigarette excise tax and performed over 52,000 alcoholic beverage and tobacco inspections in FY 18-19. A Florida Department of Children and Families overview of the 2019 Florida Youth Substance Abuse Survey by Ute Gazioch reports a final sample size of 9,819 across grades 6 through 12. Andras Khoor of Mayo Clinic Florida presents on the pathology of vaping-associated lung injury in 17 patients. The packet closes with slides from Heather Youmans on Tobacco 21 laws, retailer licensing and an e-cigarette tax for Florida.
Summary drafted by a model from the document's text below and checked by script against that text before publication. It is a navigation aid, not a reading of what the document proves. Where AI is used
Cite this document
“Florida House Business & Professions Subcommittee: Regulating Tobacco Products (October 23, 2019).”
Archived at Pandemic Darlings, https://pandemicdarlings.com/source-documents/2019-10-23-3010-business-professions-subcommittee-meeting-packets-fn-b-cd28f69c8b/
, SHA-256 47a5e39d2195c86358b98335d652d759121f78cfa16f0703a100de0449fd7401.Full text
License Population Statewid~
CD A I Cigarette D istribu tor A gent $1 00 I 5
CWD I Cigarette Wholesale Dealer $100 I 24 1
CIM P I Cig a re t te Import er $1 00 I 12
EXP I Cigarette Exporter $100 I 20
CG R I Cigar W holesale D ealer N o Fee I 6 15
TWO I Tobacco Wholesale Dealer for Other Tobacco $25 1 319
Total
1,212
RTPD Retail Tobacco Product D ealer W ith A lcohol License $ 50 23.705
RTPD Retail Tobacco Product Dealer Without A lcohol License $50 3 ,884
Tota l
2 7,589
do~r
lo11da
~ De rtment of Business
& Woress1onal Regulation ll
Excise Tax and Surcharge Collection
Tax and surcharge payments are collected at
intervals of one month, on or before the 101h of
each month, and the payment is
accompanied by statutorily required reports.
Tax and surcharge rates are dependent on the
type of product being sold.
The 2009 Florida Legislature passed the
Protecting Florida's Health Act, which levies a
surcharge on cigarettes , wraps, and tobacco
products other than cigars. Cigars are excluded
from surcharge and excise taxation per s.
210.25(12), F.S.
During FY 2018- 19, the Division collected over
$254,000,000 in cigarette excise tax, over The Division maintains an Elec tronic Data Submission (EDS) system .
$758,000,000 in cigarette surcharge, over
$38,000,000 in other tobacco products excise Approximately 90% of tax rem itting licensees are c urrently reporting
tax, and over $91 ,000,000 in other tobacco electronically
products surcharge .
do~r
londa
~ De rtment of Business
& ~fess1onal Regulation 12
Compliance Activities
In FY 18-19, the Division performed over 52,000 alcoholic beverage and tobacco inspections, with a staff of
188 dedicated Bureau of Enforcement employees across 12 district offices .
• Routine compliance inspections resulted in an approximately 64% compliance rate at the time of
inspection.
• The most common violations cited during inspections are related to a failure to post all necessary signage
and licenses, and failure to maintain records as required by law.
In FY 17-18 and FYl 8-19, the Division performed over 5,500 total tobacco compliance surveys to determine
whether licensees were complying with minimum age of purchase restrictions in Florida law.
Nearly 91 % of the aforementioned tobacco-related compliance surveys resulted in vendor compliance.
do fii)r
londa
De rtment of Business
& ~fessional Regulation 13
Revenue Distribution
Retail Tobacco Permit Fees:
10% of each retail tobacco dealer permits transferred Department of Education to provide for teacher training and for research and
evaluation to reduce and prevent the use of tobacco products by children .
Cigarette Excise Taxes:
8% to Service Charge to General Revenue Fund , and .9% to the Alcoholic Beverage and Tobacco Trust Fund to provide for operational costs.
Cigarette Excise Taxes Net (after the above reductions):
4.04% of Cigarette Excise Tax or $5,560,553 (whichever is greater) is transferred to the H. Lee Moffitt Cancer Center and Research Institute;
29 .3% of Cigarette Excise Tax collections is transferred to the Public Medical Assistance Trust Fund in the Department of Health for indigent
health care;
2.9% of Cigarette Excise Taxes transferred to Department of Revenue for the Revenue Sharing Trust Fund for counties;
1% (not to exceed $3M) is transferred to the Biomedical Research Trust Fund in the Department of Health for the advancement of cures for
cancer afflicting pediatric populations, and the balance of the cigarette tax revenue collections after payment of all of the above is
transferred to the General Revenue Fund.
Other Tobacco Products (OTP) Excises Taxes - 100% of collections are deposited directly into the General Revenue Fund .
Cigarette and OTP Surcharge Revenues - are transferred into the Health Care Trust Fund within the Agency for Health Care Administration.
do~r
londa
De rtment of Business
& Wofessional Regulation 14
Department of Business
& Professional Regulation
Contact Information
Gabe Peters
Legislative Affairs Director
gabe.peters@myfloridalicense.com
850-487-4827
do ~r
londa
~ De rtment of Business
& ~fess,onal Regulation 15
2019 Florida Youth Substance
Abuse Survey Overview
0
~
2019 Florida Youth Substance l
l
Abuse Survey Overview
Ute Gazioch, Director of Substance Abuse and Mental Health
House Business & Professions Subcommittee
_,,--
October 23, 2019
Background and Methods
• Since 2002, the Florida Youth Substance Abuse Survey is
administered each spring to public middle and high school
students across Florida.
• In even numbered years, sample size is larger to produce
county-level estimates.
• In odd numbered years, sample size is only large enough to
produce state-level estimates.
• In 2019, students were surveyed in 40 out of the 67
counties.
• Final sample size was 9,819 across grades 6 through 12.
• The margin of error is less than 2.0 percentage po~ts for
middle school and high school prevalence rates.
FLORIDA DEPARTMENT
OF CHILDREN AN D FAMIU ES
f?WFLFAM I LI ES .COM
2
Past-JO-Day Prevalence
Middle School
30% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---,
20% -+-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---,
10% +-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----f
1.3 1.2 1.0 0.8 0.6 0.4 0.4 0.4 0.3 0. 1
OC}o
~ .-.~ .,.....
~
c.P o~
,,..,.e
·~-
;:j:' •~
,,..,.~ ~-
.·.::,,
,,..,.~ -""'.,_,,,
~rzy · C
e
('
ri.<
,.,, c e'
.:,."Y1
e
~
,'lf
..¢
.~e' ~·~,,..,.e
,,{'II....
. . - o0 ~~,,{'II.' v'11,,~ ri.<.:,."Y}
,.,'>
e"
o
-~
~ ...i,,.,c ~~ '.l.... ,~ ':<:''li ~ <v ~< e' ~~ ~'li ~ ~ v ~
,.,~
.::-o o
~
,.,e
Q Jt,.'li
~-
,<'
.~
~e
<'
~e o·,~ .n<
e' ~
et(., ':.':'e
~ ~
.:,.'
e
0 ,,.§'
""'
9-'<' ~~ ·~<'"Y} ·~<'~ ~~ vo.:,. +Q ,<$',q ~,<$' b ~<'
4 tr,, ··~'li ~ 4 ~q, ~+ <lf ~ +tr eo' ~<' voe.;
~.... "~ ~ ~ <J."
~ ~
O
~e<"
v
,vri. ..
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
MYF LFAMI LI ES .COM
3
Past-30-Day Prevalence
High School
30% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~,
20% \
10%
1.4 1.4 1.2 1.2 I.I I. I 0. 9 0. 7 0.5 0.4 0.'3
0%
~ • ~<ll •~ ~'1>- • <'~ <ll' ~ ~"' ,LO."' ~"' <"' <ll' ~'1>- ~ lt' ~
. <'<ll
~ ~ ~ , ~ 6 ~ ~ ~ ~ , ~ , ~ ~
~c; ..S..f'
j\~
0
:t
~,z,.~ <~ Qi.S- ,·,~
J.,.'1>-
~<ll <Q
~<ll ~<
<ll'"'
....~
'!.
0
~~ ~<ll
'" • ~~<ll ~<lit<., ~
,z,.<f:"
J.,.'1>-
i~
....§>
Q
0
<v
~<ll
~;:,;
i:'O O ~• ;,,<ll ""' ~ <ll" J...'V • (.)' <ll ~
ii<:- ~,z,. ·~<'~ <i,'""'O v o~ ..+Q <'b~ • ~~ <f:"q, i~·e, e,~<:- ,z,.<f:"
~ .·~ ~,z,.q, e: .q..: ,z,. ~+ ..+fr ~ vo ~
J...~...
~-
;(..."<:-
~, ~
cJ '\ ~ ,-\<:- ~<ll
o~<ll ~'\
v'
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
4 AvfLfAM1uEs.coM
Alcohol
Past-30-Day Prevalence by Grade Cohort
50% -,-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--,
40.8 42.0
40%
I •
• • • ...._
30%
I 20.3
19.7
20%
I ~ '> I '>
19.8
10%
I ~ -
I
8.3 T
7.3 8.
I
0%
2002 2004 2006 2008 2010 2012 2014 2016 2018 2019
[ ....: Mid~dl~~School --- High School ~]
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
5
N\yf lfAMI Ll ES.COM
Binge Drinking
Prevalence by Grade Cohort
40% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
30% +-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
22.3 23.0
20% l-~~~~~~~~~~---=~~"""'"-1~~~~~~~~~~~~~~~~~~
•
9.6
• I
9.3
0% +-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
3.2 3.1
2002 2004 2006 2008 2010 2012 2014 2016 2018 2019
j _._ Middle School .,._ High School I
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
MYFLFAMILI ES.COM
6
Alcohol and Driving Trell·ds
Past-30-Day Prevalence Among High School Students
40% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
30% -+-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-
20% .....__ _
10% - ! - - - - -
0% - + - - ---I
2012 2014 2016 2018 2019 2012 2014 2016 2018 2019
[ rtidi~g··~ith· ~· o;i~-ki~g . o~i~~;~j Driving after Drinking
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
~YFLFAMILI ES.COM
7
Cigarettes
Past-30-Day Prevalence by Grade Cohort
20% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
14.9 15.0
15%-i-~ ~ - -...~:::::-~~~~~~~~~~~~~~~~~~~~~~~,
10%
7.1
I ........... • ....._ ~ ., r I
..
. 5%
I2 --..........._ 2.1
.......
• 1.0
0% -l-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-,-~~---t
2002 2004 2006 2008 2010 2012 2014 2016 2018 20
[ _._ Middle School .... High School I
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
8
;{.\yflfAMI LI ES.COM
Marijuana
Past-JO-Day Prevalence by Grade Cohort
25% ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--,
20%
15%
17.2
. . • 7 18.6 •
. . _____
• 18.6
·~
16.3
-- -
15.4
---
10% 1-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~11
5.9 5.7
,I I
• J
5% I • • • •
3.7 3.7
3.2
0%
2002 2004 2006 2008 2010 2012 2014 2016 2018 2"019
j _._ Middle School .._ High School I
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
9
AAvF LFAM1 u ES.COM
Use of Any Illicit Drug (Other than Mari.juana)
Past-30-Day Prevalence by Grade Cohort ·
15% .-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-,
.
10.6 10.9
10% I ~ ~..
~ ---T
~ ""-..
. ..
............... \ 1
5.
s.
5% S.6 S.S
0%
2002 2004 2006 2008 2010 2012 2014 2016 2018 019
,~~ -+- Middle School -D-·· High Scho~ I
10 1 FLORIDA DEPARTMENT
OF CHILDREN AND FAMIUES
'MYFLFAMlLI ES.COM
Prescription Pain Relieve~s
Past-30-Day Prevalence by Grade Cohort
10% -,-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---,
5%-+-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~
4.4 . • •
2.4 .
. . t
.- 1.3
1.0 1.1
0% ---~~~~~~~~~~-,-~~~~~~~~~~-,-~~~~~~~~~~-,-~------<
2002 2004 2006 2008 2010 2012 2014 2016 2018 2019
[ ~ ..;:.~~~ddle School _.. Hig~~~~~~J
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
MYFLFAMILI ES .COM
11 11
Vaping Nicotine and Vaping MariJuana
Lifetime and Past-30-Day Prevalence
40%
I
30% ,
20%
10%
0%
H.S. Full
I
M.S. H.S. Full M.S. H.S. Full M.S. H.S. Full M.S.
Sample Sample Sample Sample
Lifetime Past-30-Day Lifetime Past-30-Day
Nicotine Vaping Nicotine Vaping Marijuana Vaping Marijuana Vaping
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
'MYfLFAMIU ES.COM
12
Vaping Nicotine and Smoking Ciga~ettes
Past-30-Day and Lifetime Prevalence
[~~v~pi~~ Ni~~1:in~ .·1 Tried Cigarettes
71.9% of current vapers have never tried cigarettes.
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
iNi_yf LfAMI LI ES.COM
13
Trend Summary
• Among high school students, alcohol, cigarette, marijuana, and
Rx pain reliever use continue their long-term decline.
• Among middle school students, the substance use decline has
stalled.
• The majority of students who vape nicotine did not
transition from smoking cigarettes. Their vaping is
independent of cigarette use.
FLORIDA DEPARTMEN T
OF CHILDREN AND FAMILI ES
'N\yflfAMI LI ES .COM
14
Questions?
FLORIDA DEPARTMENT
OF CHILDREN AND FAMILIES
%\vF LFAMI LI ES.COM
15
Pathology of Vaping-Associated
Lung Injury
MAYO
CLINIC
Pathology of Vaping-Associated Lung
Injury
Andras Khoor, MD, PhD
Mayo Clinic Florida
©2019 MFMER I slide-1
Tht NEW ENGLAND JOURNAL of MEDI C INE
I CORRESPONDENCE ·····~~~----·1
Pathology ofVaping-Associated Lung Injury
TO THE EDITOR: Despite the accumulating data criteria for a "confirmed" diagnosis of \rapin~-
on the clinical and imaging features of vaping- related lung injuryi the remaining six met the
associated lung injury, 1•2 its pathology is poorly criteria for a u probable" designation. In aJ I cases
understood. We reviewed lung biopsies from 17 bistopathological findings showed patterns of
patients (13 men; median age, 35 )fears (range acute lung injury, including acute fibrinous pneu-
19~67]), all of whom had a history of vaping monitis, diffuse alveolar damage, or organ izin
(71% with marij uana or cannabis oils) and were pneumonia, usuaJly bronchiolocentric and accom-
clinically suspected to have \raping-associated llllg panied ~ , bronchiolitis (Fig. li also see the Supple-
injury. Presentation was acute or subacute in all mentary Appendix, available with the fuJl text of
cases, with bi latera l pulmonary opacities; all but this letter at NEJM .org). No histologic findings
n,vo patients presented in 2019. E]even met the were specific, but foam y macrophages and pneu-
A
Butt YM, et al. N Engl J Med. 2019 Oct 2. [Epub ahead of print]
Authors
• Mayo Clinic Scottsdale, AZ • Mayo Clinic Jacksonville, FL
• Yasmeen M. Butt, M.D. • Andras Khoor, M.D., Ph .D.
• Maxwell L. Smith, M.D. • Isabel Mira-Avendano, M.D.
• Henry D. Tazelaar, M ~D. • UnityPoint Health Peoria, IL
• Laszlo T. Vaszar, M.D. • Aiyub Patel, M.D.
• Karen L. Swanson, D.O.
• Mayo Clinic Scottsdale, AZ
• Mayo Clinic Rochester, MN • Brandon T. Larsen, M.D.,
• Matthew J. Cecchini, M.D., Ph.D.
Ph.D.
• Jennifer M. Boland, M.D.
• Melanie C. Bois, M.D.
• James H. Boyum, M.D.
• Adam T. Froemming, M.D.
MAYO
CLINIC
~ ©2019 MFMER \ sltde-3
Introduction
• Use of electronic cigarette ("e-cigarette")
devices has exploded in popularity in recent
years
• These battery-operated devices
• heat liquids, oils, or waxes containing
nicotine, cannabinoids, synthetic
cannabinoids, illicit drugs, and other
chemical compounds,
• producing an aerosolized vapor
• that can be inhaled, or vaped, by the user
MAYO
CLINIC
~ ©2019 MFMER I s!lde-4
Aim
• To characterize the pathologic changes that occur
in the lung:
• Exogenous lipoid pneumonia?
• Much recent attention has been given to the
possibility that vaping-associated lung injury
may represent exogenous lipoid pneumonia
• Acute lung injury pattern?
• Acute lung injury patterns include:
• acute fibrinous pneumonitis,
• diffuse alveolar damage, and
. . .
• organ1z1ng pneumonia
MAYO
CLINIC
~ ©2019 MFMER I slide-5
Methods
• The study was approved by the Institutional
Review Board at Mayo Clinic (IRB# 19-008434)
• In all cases,
• a diagnosis of vaping-associated lung injury
was favored clinically, and
• biopsies were performed to confirm this
clinical impression and rule out other causes
MAYO
CLINIC
~ ©2019 MFMER I sltde-6
Methods (continued)
• Cases were classified using criteria for vaping-
related lung injury recently proposed by the CDC
• "Confirmed"
• 1) use of an e-cigarette or vaping device
within 90 days of symptom onset
• 2) presence of pulmonary infiltrates
• 3) absence of clinical and laboratory
evidence of infection
• 4) absence of evidence for alternative
diagnoses
• "Probable"
• Identical criteria with the exception of #3
MAYO
CLINIC
~ ©2019 MFMER I slide-7
Results: Patient Demographics
• A total of 17 patients met the inclusion criteria
• Most patients were
• young adults (median age 35 years, range
19-67) and
• most were men (76°/o)
MAYO
CLINIC
ctP ©2019 MFMER I sllde-8
Results: Clinical Findings
• Eleven patients met CDC criteria for a
"confirmed" diagnosis, with the remaining six
patients meeting CDC criteria for a "probable"
designation
• All patients had a history of vaping in the weeks
and days prior to presentation
MAYO
CLINIC
~ ©2019 MFMER J shde-9
Results: Clinical Findings (continued)
• Two patients were vaping in an attempt to quit
smoking tobacco
• Twelve patients (71 °/o) reported vaping
• tetrahydrocannabinol (THC),
• cannabis oils,
• cannabidiol (CBD), or
• other non-nicotine products
• Both manufactured prepackaged vape pods
and open access tank style vaporizers were
used
MAYO
CLINIC
~ ©2019 MFMER I slide-10
Results: Pathologic Findings
• In all cases, pathologic findings showed
patterns of acute lung injury, including
• acute fibrinous pneumonitis
• diffuse alveolar damage, or
• • •
• organ121ng pneumonia
.• None of our cases showed histologic evidence
of exogenous lipoid pneumonia
MAYO
CLINIC
~ ©2019 MFMER I slide-11
Supple1nentary Table S3. Frequency of Histopatbologic Feah1res in Vaping-
Associated Acute Lung Injury
Histologic Feature ~umber of cases ,vitb feah1re I
~umber of cases with relevant
struch1res present for evaluation (0/o)
Foa111y I Vacuolated Macrophages 17 I 17 (100)
Foamy I \ i acuolated Pneu1nocytes 17 I 17 (100)
Intraalveolar Fib1in 16 I 17 (94)
Organizing Pneu1nonia 14 I 17 (82)
Bronchiolitis 7 I 9 Q_~
Bronchiolar Iviucosal Ulceration 6 I 9 ( 67)
Interstitial Edema 11 I 1 7 (§_~
Neutropbils 9 / 17 (53)
Chronic Interstitial hrllammation 9 I 1 7 (53)
Pigmented Macrophages 7 I 17 (4 1)
Eosinophils 5 I 17 (29)
Hyaline Membranes 4 I 17 (24)
Pe1ibronchiolar Metaplasia 2 I 9 (22)
Organizing Fibrinous Pleu1itis 1* I 7 (14)
Interstitial Fibrosis 1 I 17 {§)
Pleural Fibrosis O I 7 (Q}
Granulomas O I 17 {Q2
Exogenous Lipoid Pneumonia O I 1 7 (0
Case #17
• 19-year-old man presented with
• cough,
• pain when swallowing,
• nausea, and
• vomiting
MAYO
CLINIC
~ ©2019 MFMER I slide-13
Chest CT
;,
Case #17 Normal lung
MAYO
CLINIC
Cry ©2019 MFMER I sllde-14
Chest CT
Case
'-0" #17 __J
""""'"ER,'"''·"
'
L. ..
E
E
M
~
~
Q)
Cl)
co
0
ro
E
L..
0
z
Q)
en
ro
()
Results: Outcomes
• Information was available in seven patients:
• two patients (both with diffuse alveolar
damage) died of their illness
• the other five were improving or improved at
the time of last follow-up
MAYO
CLINIC
Cry ©2019 MFMER I slide-19
Conclusions
• We believe that the histologic changes suggest
that vaping-associated lung injury represents
• a form of airway-centered chemical
pneumonitis from one or more inhaled toxic
substances
• not exogenous lipoid pneumonia
• The agents responsible remain unknown
MAYO
CLINIC
~ ©2019 MFMER J slide-20
::::,
'U
Q)
0
>.
ro
E
@)
(/)
~
'U
c
ro
~
0
0
..c
~
E-cigarette Liquid Composition
• Propylene glycol
• Glycerin
• Contaminants, including
• polycyclic aromatic hydrocarbons,
• nitrosamines,
• endotoxins,
• diacetyl, and
• a wide variety of other organic and inorganic
chemicals and flavoring compounds
MAYO
CLINIC
Cry ©2019 MFMER I slide-22
Regulating Tobacco Products
• ..
Cancer Action
NetworksM
Regulating Tobacco Products
Florida House of Representatives
Business & Professions Subcommittee
Wednesday, October 23, 2019
Heather Youmans
Senior Directo~ Florida Government Relations
•
fflj
~"cancer Action
Network·
••••••••••••••••••••••••••••••••••• ~-
• Regular and significant increases in taxes on all tobacco products,
including e-cigarettes
• Comprehensive smoke-free laws that include e-cigarettes
• Fully funding and implementing tobacco control programs in
accordance with US Center for Disease Control's (CDC's) Best
Practices
• Comprehensive coverage of US Food and Drug Administration
(FDA) approved cessation treatments and individual, group and
phone counseling
•
•
~t.ancer Action
••••••••••••••••••••••••••••••••••• ffili i
• Raising the age of sale to 21 for all tobacco products
(Tobacco 21) with strong retailer compliance and
active enforcement
• Restricting the sale of ALL flavored tobacco products,
including menthol cigarettes
• Protecting authority to pass local laws, stronger than
the minimum standard set by state laws
•
Policy Background - •
~ancer Action
Electronic Cigarettes
••••••••••••••••••••••••••••••••••• ~-
• Sottera., Inc. v. Food & Drug Administration., 627
F.3d 891 (D.C. Cir. 2010)
- In 2008, the FDA stopped shipments of e-cigarettes into the United States
- The FDA claimed the products were unapproved drug-device combination
products under the Federal Food, Drug, and Cosmetic Act that were
intended to help treat the withdrawal symptoms of nicotine addiction
- Two e-cigarette distributors sued the FDA requesting a preliminary
injunction. They claimed the products were tobacco products for "smoking
pleasure," not drug-device combination products
•
Policy Background - •
ffli ;~twork~
~ancer Action
Electronic Cigarettes
••••••••••••••••••••••••••••••••••• )!..-
Between the filing of the lawsuit and a decision for a preliminary injunction, Congress
passed the Family Smoking Prevention and Tobacco Control Act (Tobacco Control Act)
and it was signed into law.
Ultimately, The D.C. Circuit found that under the Tobacco Control Act, all products made
or derived from tobacco and intended for human consumption that are "marketed for
therapeutic purposes" are subject to FDA's drug and/or device provisions, whereas
"customarily marketed tobacco products" are subject to regulation as "tobacco
products".
The FDA decided not to appeal the decision to the Supreme Court and instead issued a
statement of its intent to regulate e-cigarettes as a tobacco product .
•
What is considered a ''Tobacco •
Product''?
ffjj
~""cancer Action
Network~
•••••••••••••••••••••••••••••••••••
FDA finalized a rule, effective
~-
August 8, 2016
• Hookah (waterpipe)
• Cigarettes
tobacco
• Smokeless tobacco
• Pipe tobacco
• E-cigarettes and other
Electronic Nicotine Delivery• Cigars
Systems (ENDS) • Nicotine gels
• Dissolvables
•
•
~ancer Action
fflj
~~twork•
••••••••••••••••••••••••••••••••••• ~-
• FDA has yet to require e-cigarettes to go
through premarket review and receive a
marketing order from the FDA
• FDA has not removed flavored e-cigarettes
including, mint and menthol, from the market
Current State Regulations •
of E-cigarettes ffii
~tancer Action
Network~
••••••••••••••••••••••••••••••••••• ~-
• Only 4 states fund tobacco control programs at more than
50% of CDC's recommended funding level
• Only 18 states and DC have excise taxes on e-cigarettes
- Only 7 of these states come close to taxing them at a
rate parallel to the state tax on cigarettes
• Only 18 states and DC prohibit the use of e-cigarettes in
100% smoke-free venues
•
•
~"cancer Action
••••••••••••••••••••••••••••••••••• ffi! iii
• E-cigarettes are not defined as tobacco products
- E-cigarette retailers are not required to obtain a tobacco license
• No excise tax on e-cigarettes
• E-cigarettes were just added to the Florida Clean Indoor Air Act
(Amendment 9), but all smoking is still allowed in stand-alone bars
• E-cigarettes were added to the program of work for Tobacco Free
Florida, but the program is only funded at 36.3% of CDC's
recommendation and additional spending authority provided for
education exclusively focused on youth
•
•
ffii
~"'cancer Action
N.etwork~
••••••••••••••••••••••••••••••••••• ~-
• No type of counseling (individual, group, or
telephone) and no FDA approved tobacco cessation
medication coverage for Medicaid enrollees
• 2 local jurisdictions have Tobacco 21 laws
•
•
fflj
~tancer Action
)!;i -
Network~
Tobacco 21 - Evidence-Based Policy
•••••••••••••••••••••••••••••••••••••••••••••••••••••••••••
What Does a Comprehensive Tobacco 21
Law Include?
• Covers all tobacco products, including • Does not create new categories of
electronic cigarettes products, which would exempt them from
• Provides public education and training and other tobacco control laws
technical assistance
, to retailers • Does not penalize youth
• Implements measures for active • Does not preempt other jurisdictions from
enforcement, such as retailer licensing and passing strong tobacco control laws
penalties, including license suspension and
revocation
•
•
fflj
~!ancer Action
Network*
••••••••••••••••••••••••••••••••••••••••••••••••••••••••••• ~-
• State & Local State-of-Play
- 18 states, DC and at least 500 localities now
have T21 laws
• Strength of the laws vary widely
State Tobacco Retailer •
~t.ancer Action
Licensing Laws
••••••••••••••••••••••••••••••••••• ffil &
• 37 states and DC require retailers that sell
cigarettes to obtain a license or permit
• 36 states require a retailer license to sell other
tobacco products
• 20 states require a retailer license to sell e-cigarette
•
~"cancer Action
••••••••••••••••••••••••••••••••••• ~-
• Florida needs to take a comprehensive approach to
combating the tobacco and e-cigarette epidemic
- Update the definition of "tobacco products" to include all products that are
available on the market
- Require tobacco retail licensing for all retailers, including e-cigarette retailers
- Legislation increasing the age of sale for tobacco products should include all
products, all people and preserve local control
- Impose a State Tax: 85% of wholesale price would put e-cigarettes inline with
the tax on other non-cigarette tobacco products
•
•
fflj
~"'cancer Action
Network~
••••••••••••••••••••••••••••••••••• ~-
Heather Youmans
Senior Director, Government Relations
Heather.You ma ns@cancer.org
www.FightCancer.org
File and source
- File
- 2019-10-23_3010_business-professions-subcommittee_meeting-packets_fn-bps-10-23-19.pdf
- Size
- 18,671,992 bytes
- SHA-256
- 47a5e39d2195c86358b98335d652d759121f78cfa16f0703a100de0449fd7401
- Original
- No public link identified.